New process allows labs to use same Pap test vial instead of transferring sample to new vial, thus simplifying workflow INDIANAPOLIS, June 26, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) ...
Pelvic exams are no one’s idea of fun. No matter how many you’ve done, no matter how prepared you are, that moment when the ice cold speculum wrenches open your vagina never gets more comfortable. As ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved expanded indications for the self-collection of vaginal swabs for HPV tests. The approval will ...
A test that can detect the DNA of the human papilloma virus (HPV), to confirm the need for cervical cancer screening in women 25 years and older, has gained the FDA’s support as a primary screening ...
The first shipments of self-collection HPV tests for cervical cancer screening are making their way to labs and health care facilities across the United States. The Food and Drug Administration gave ...
Each year, about 11,500 U.S. women are diagnosed with cervical cancer and about 4,000 women die from it, according to the U.S. Centers for Disease Control and Prevention. Photo by Adobe ...
(RTTNews) - Biopharmaceutical company Roche Holding AG (RHHBY), announced on Tuesday that its cobas HPV test for use on the cobas 6800/8800 Systems has been awarded the World Health Organization (WHO) ...
The U.S. Food and Drug Administration (FDA) has approved a human papillomavirus (HPV) DNA test for women 25 and older that can be used to determine whether these women should have additional ...
Pap smears and HPV tests can catch issues early—long before they become cancer. Learn why these simple screenings matter and how to make the experience more comfortable.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results